-
Thukukile Zuma Resigns from ANC Johannesburg Leadership Amid Disciplinary Dispute
-
Russia Orders 100,000 Kometa Modules to Counter Ukrainian Electronic Warfare
-
CM Mohan Yadav Meets Bohra Spiritual Leader to Discuss Simhastha 2028 and Development
-
Mahayuti-backed Rajesh Patil Elected Chairman of Gokul Dairy Amidst Political Deadlock
-
Eli Crane Defeats Jonathan Nez in Tight Arizona Congressional Race
-
David Walliams Identified as Celebrity in Sexual Misconduct Allegations After Legal Bid
-
Sherilyn Smith Encourages Women to Embrace Scars as Symbols of Resilience
-
Korea's Severe Asthma Patients Blocked from Biologics by Restrictive Reimbursement Rules
-
Belgium Signs Contract for 20 Rheinmetall Skyranger Air Defence Systems
-
Shanghai Science and Technology Museum Signs Pacts With London and Ottawa Institutions at CIIE
-
NextBoat Inc. to Announce Third Quarter 2026 Financial and Operating Results on Monday, November 16, 2026
-
Shooting Victim Lawyer in Philadelphia David P. Thiruselvam Explains When Property Owners and Businesses Can Face Civil Claims After a Shooting
-
Retired Army Officer Earns Two Degrees While Navigating Family Health Challenges
-
Remergify Opens Waitlist for AI Allowance, a Plain-English Way to Let AI Assistants Shop Within Limits You Set
-
An Investigational Drug to Tackle Measles Outbreaks
-
Ondas Receives Purchase Order for Next-Generation Tactical Attack Drones, Aims to Leverage Planned ARAN Defense Acquisition to Manufacture Thousands of Systems
-
First Breach Plans to Integrate Onboard AI Computing into CQS and LRS Drone Platforms
-
Stabilis Solutions Announces Three-Year Take-Or-Pay LNG Supply Agreement with Existing Aerospace Customer
-
ACCESS Newswire Reports Third Quarter 2026 Results
-
T4 Robotics Appoints Paul Hughes as Co-CEO and Announces Expansion into Unmanned Maritime Systems
-
ClearSign Receives Order for "M1" Series Burner from Tulsa Heaters Midstream (THM)
-
Kalm with Kava and Pū'iwa Farms Hawai'i Bring Fresh Frozen Hawaiian Kava to Market
-
Innovative Menopause Medicine from JASTLabs Advances Patent Protection Internationally
-
SMX Advances Development of its Scientific Intelligence, an AI-Powered Platform Intended to Create a Comprehensive Codex for Chemical Agents, Additives and Supplements
-
Jerash Holdings Reports Fiscal 2027 Second Quarter Financial Results
-
Four Nines Gold Intersects 67 Metres at 1.78 g/t Gold, Reinforing Emerging Gold Corridor at Hayden Hill
-
Peraso to Showcase DUNE 60 GHz Wireless Platform at Africa Tech Festival 2026
-
Your Patients Are Asking AI About You. AimwellBio Lets Every Physician See the Answer, Free.
-
ByNext Joins the Bilt Neighborhood: Reaching More Customers by Integrating Its Technology with Bilt Neighborhood OS
-
ATWEC Technologies, Inc. (OTCID:ATWT) Reports Third Quarter 2026 Revenue of $12.46 Million, Up 37% Year-over-Year
-
Cardiff Lexington To Report Third Quarter 2026 Financial Results and Host Conference Call on Monday, November 16, 2026
-
Horizon Aircraft Completes Preliminary Design Review of Cavorite X7 Hybrid eVTOL
-
Securitas Healthcare Introduces a New Era of RTLS Built for the Future of Healthcare Operations
-
BioTech Breakthrough Acknowledges Champions Oncology Innovation with the "Contract Research and Development Innovation Award"
-
Allstar Health Brands Confirms MLS NEXT Expansion Bid to Anchor a Permanent Training Structure and a Professional Pathway
-
SNZweig Forms AEC Industry Advisory Council
-
Critical Elements' 10,000-Meter Summer Drill Program at Rose West Continues to Deliver Positive Results
-
New Gold IRA Investing Guide Explains How to Buy Gold in an IRA for American Consumers
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - November 10
-
Fulcrum Metals PLC Announces Fulcrum to Increase Shareholding in Loyalist
-
Spectrocell Strengthens Product Discovery and Customer Engagement with Bioz Badges
-
3D Induced Polarization Survey Identifies a Large Drill Target at East Goldfield
-
Apex Extends Trinity Zone in West Step-out Drilling With 2.52% REO Over 223.3 m and 2.49% REO Over 123.3 m at Rift
-
KIFFIK Biomedical Recognized as Top Biomarker Access Technology 2026 by Life Sciences Review
-
Zomedica Announces "Third Friday at Four" Webinar on November 20, 2026: The People Behind Zomedica - Seven Guiding Principles in Action, and Q3 Financial Results
-
Precigen Posts Strong Q3: PAPZIMEOS Net Revenue Rose 37%; Positive Cash Flow Achieved Ahead of Schedule
-
Geek+ Unveils 24/7 Warehouse Autonomy Plan to Advance Self-Optimizing, Around-the-Clock Operation
-
Gamma Resources Announces Planned Radon Flux Baseline Survey at Mesa Arc Uranium Project in New Mexico, Provides Update on Project Timelines
-
China Explores a New Pathway for Medical AI: Bridging R&D Innovation and Clinical Adoption
-
Odyssey Behavioral Healthcare Launches Virtual Intensive Outpatient Mental Health Treatment for Adults
Vanta Announces Appointment of Chief Financial Officer and Corporate Secretary
VANCOUVER, BC / ACCESS Newswire / November 10, 2026 / Vanta Holdings Inc. (CSE:VNTA)(OTC PINK:VNTXF)(FSE:7BC, WKN:A4205J) ("Vanta" or the "Company"), a consumer health sciences and longevity company focused on preventative wellness and healthspan extension, and parent of the Vanta premium longevity brand, announces the appointment of Mr. David Goertz, CPA, CA, as Chief Financial Officer and Corporate Secretary of the Company, effective November 9, 2026.
About David Goertz
Mr. David Goertz, CPA, CA, is a financial executive and corporate director with more than two decades of experience providing accounting, assurance, financial reporting and business advisory services to public and private companies in Canada and the United States.
Mr. Goertz is a Partner at DMCL LLP, a Canadian chartered professional accounting firm he joined in 2005, becoming a partner in 2011. His experience includes public company operations, restructurings, acquisitions and initial public offerings across industries including technology, manufacturing, mining and real estate.
His executive experience includes serving as Chief Financial Officer of Nasdaq-listed DevvStream Corp., including through its 2024 business combination and Nasdaq listing. He also serves as an Independent Director and Chair of the Audit Committee of NorthStrive Acquisition Corp I., a Nasdaq-listed special purpose acquisition company.
Mr. Goertz holds a Bachelor of Commerce from the University of Victoria, obtained his Chartered Accountant designation in 2004 and holds the Chartered Professional Accountant (CPA) and Chartered Accountant (CA) designations.
Mr. Goertz succeeds Mr. Dallas Pretty as Chief Financial Officer and Corporate Secretary, effective November 9, 2026. The Company extends its sincere appreciation to Mr. Pretty for his service and contributions and wishes him success in his future endeavors.
About Vanta Holdings Inc.
Vanta Holdings Inc. (CSE:VNTA) (OTC:VNTXF) (FSE:7BC0, WKN:A4205J) is a consumer health sciences and longevity company focused on premium hydration, nutraceutical products and the development of U.S.-focused peptide initiatives. Through its Vanta brand and select private-label partnerships, the Company develops, manufactures and distributes premium hydration and nutraceutical products, including its flagship Blackwater and BlackPowder product lines, which feature bioactive compounds, and trace mineral complexes. Vanta's operations include ownership of a natural alkaline spring water aquifer and a 40,000-square-foot, Health Canada and HACCP-certified manufacturing facility in British Columbia. Vanta is also pursuing opportunities in the U.S. peptide sector, including potential commercialization arrangements with compounding pharmacies, subject to applicable regulatory requirements.
On behalf of the Board of Directors:
Martino Ciambrelli, Director
[email protected]
604-449-1816
Disclaimer for Forward-Looking Information
This news release contains forward-looking statements within the meaning of applicable securities laws. Forward-looking statements are based on management's current expectations, estimates, assumptions and projections that are believed to be reasonable as of the date of this news release, including assumptions regarding the availability of suitable opportunities, commercial partners, financing and lawful regulatory pathways. Such statements include the Company's development of U.S.-focused peptide initiatives and pursuit of potential commercialization arrangements with compounding pharmacies. These statements are subject to risks and uncertainties, including financing constraints, reliance on commercial partners and applicable regulatory requirements, which may cause actual results to differ materially. There can be no assurance that these initiatives will result in definitive agreements or commercial operations. Except as required by applicable securities laws, the Company undertakes no obligation to update or revise any forward-looking information to reflect new information, future events or otherwise. Readers are cautioned not to place undue reliance on forward-looking statements and are encouraged to consult the Company's continuous disclosure filings available under its profile on SEDAR+ for additional risk factors and further information.
SOURCE: Vanta Holdings Inc.
View the original press release on ACCESS Newswire
L.Harper--AMWN